Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND
As Previously Announced, Reldesemtiv Had No Effect on the Primary Endpoint of Change from Baseline in ALSFRS-R or Key Secondary...
Read moreAs Previously Announced, Reldesemtiv Had No Effect on the Primary Endpoint of Change from Baseline in ALSFRS-R or Key Secondary...
Read moreUnited States Periodontal Gel Sales Witness a Spike Due to Increasing Prevalence of Periodontal Diseases in the Country and the...
Read moreAdds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology ResearchLEXINGTON, Mass.,...
Read morePhase 1 combination dose escalation expected to support planned Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) Updated...
Read moreWALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that on December 6, 2023, it...
Read moreCelebrating International Civil Aviation Day, Airlink CEO Steve Smith urges businesses across the supply chain to emulate the aviation industry's...
Read moreIncreased canopy with new, premium genetics, and enhanced extraction, processing, and manufacturing capabilities positions Acreage to be a top in-state...
Read moreEATONTOWN, N.J., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary...
Read moreKey collision avoidance system market players include General Electric Company, Robert Bosch GmbH, Honeywell International Inc., Hexagon AB, DENSO Corporation,...
Read moreSAN FRANCISCO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the...
Read more